文献速递头颈外科

头颈癌患者牙关紧闭患病率:一项系统评价与Meta分析

Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
PubMed 文献 · Head Neck · 2019-06-19

该系统评价与Meta分析检索4个数据库至2018年4月,纳入23项研究(前瞻性队列15项、随机临床试验3项、横断面5项)定性分析、15项进入Meta分析,共2786例接受手术、放疗和/或化疗的头颈癌患者。牙关紧闭(最大张口度≤35 mm)加权平均患病率从基线17.3%(95%CI 10.8%-26.5%)升至6个月峰值44.1%(95%CI 36.7%-51.8%),12个月降至32.1%(95%CI 27.2%-37.4%),3-10年维持在平均32.6%(95%CI 22.0%-45.3%)。

要点

  • 牙关紧闭定义为最大张口度≤35 mm,加权平均患病率6个月达峰值44.1%。
  • 患病率随时间变化:基线17.3%、12个月32.1%、3-10年32.6%。
  • 基于单项研究,原发部位为口腔或口咽与牙关紧闭风险较高相关。

核心结论

  • 头颈癌患者牙关紧闭加权平均患病率从基线17.3%升至6个月峰值44.1%,12个月降至32.1%,3-10年维持在平均32.6%。
  • 基于单项研究,原发部位为口腔或口咽与发生牙关紧闭的较高风险相关。
  • 需要开展具有多次客观牙关紧闭测量、评估疾病特征和治疗变量的前瞻性队列研究或随机对照试验,以进一步研究头颈癌治疗继发牙关紧闭的患病率。

研究设计与样本

  • 系统评价与Meta分析,检索Cochrane Library、MEDLINE、EMBASE和Web of Science至2018年4月。
  • 证据等级基于牛津循证医学中心评估。
  • 纳入英文发表、报告牙关紧闭为最大张口度≤35 mm的前瞻性队列研究(n=15)、随机临床试验(n=3)和横断面研究(n=5)。
  • 共审阅636篇摘要,23项研究纳入定性分析,15项纳入Meta分析。
  • Meta分析共纳入2786例接受手术、放疗和/或化疗(单独或联合)的头颈癌患者。

主要发现

  • 牙关紧闭加权平均患病率从基线17.3%(95%CI 10.8%-26.5%)升至6个月峰值44.1%(95%CI 36.7%-51.8%)。
  • 12个月患病率降至32.1%(95%CI 27.2%-37.4%),3-10年维持在平均32.6%(95%CI 22.0%-45.3%)。
  • 基于单项研究,原发部位为口腔或口咽与发生牙关紧闭的较高风险相关。

关键数值与推荐

  • 牙关紧闭定义为最大张口度≤35 mm。
  • 加权平均患病率:基线17.3%(95%CI 10.8%-26.5%)、6个月44.1%(95%CI 36.7%-51.8%)、12个月32.1%(95%CI 27.2%-37.4%)、3-10年32.6%(95%CI 22.0%-45.3%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要开展具有多次客观牙关紧闭测量、评估疾病特征和治疗变量的前瞻性队列研究或随机对照试验,以进一步研究头颈癌治疗继发牙关紧闭的患病率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this systematic review and meta-analysis was to determine the prevalence of trismus in patients with head and neck cancer. METHODS: Four electronic databases were searched: Cochrane Library, MEDLINE, EMBASE, and Web of Science up to April 2018. Level of evidence was assessed based on Oxford Centre for Evidence-based Medicine. Publications were restricted to prospective cohort studies (n = 15), randomized clinical trials (n = 3), and cross-sectional studies (n = 5) reporting on trismus as mouth maximum opening less than or equal to 35 mm in the English language. RESULTS: A total of 636 abstracts were reviewed for inclusion. Twenty-three studies were included in qualitative analysis and 15 studies in meta-analysis. The results included 2786 patients with head and neck cancer treated with surgery, radiotherapy, and/or chemotherapy either alone or in combination. Based on meta-analyses, the weighted average prevalence of trismus increased from 17.3% at baseline (95% confidence interval [CI], 10.8%-26.5%) to a peak of 44.1% at 6 months (95% CI, 36.7%-51.8%) and decreased to 32.1% at 12 months (95% CI, 27.2%-37.4%) and continued in average 32.6% at 3-10 years (95% CI, 22.0%-45.3%). CONCLUSIONS: Having a primary site of the oral cavity or oropharynx was associated with a higher risk for developing trismus based on individual studies. Prospective cohort studies or randomized controlled trials with multiple objective trismus measurements, evaluation of disease characteristics, and treatment variables are needed to further investigate the prevalence of trismus secondary to head and neck cancer treatment.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Watters AL, Cope S, Keller MN, et al. Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis. Head Neck. 2019. PMID: 31215723. doi:10.1002/hed.25836

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。